Medicare claims for Alzheimer's disease skyrocket 250 percent...Studies describe devastating international
cost of Alzheimer’s disease

Philadelphia, July 19, 2004 – The rate of Medicare beneficiaries identified as having Alzheimer’s disease rose 250 percent during the 1990s, according to a study reported at The 9th International Conference on Alzheimer’s Disease and Related Disorders (ICAD), presented by the Alzheimer’s Association. This and three other studies suggest that Alzheimer’s disease is the public health crisis of the 21st century as diagnosis and awareness of Alzheimer’s disease increases.

“Unless a prevention or cure is found soon, Alzheimer’s disease will overwhelm our already stretched healthcare system and bankrupt Medicare and Medicaid,” said Sheldon Goldberg, president and CEO, Alzheimer’s Association. “Medicare expenditures for people with Alzheimer’s are almost three times higher than the average for all beneficiaries. And, Medicare spending for beneficiaries with Alzheimer's will triple between now and 2015, from $62 billion in 2000 to $189 billion in 2015. State and federal Medicaid spending on people with Alzheimer's disease, for nursing home care only, is estimated to rise from $19 billion in 2000 to $27 billion in 2015.”

The Medicare claims study, by P. Murali Doraiswamy, M.D., Donald H. Taylor Jr., Ph.D., and Frank Sloan, Ph.D., at Duke University, analyzed data from approximately 30,000 Medicare beneficiaries from 1991 to 1999. The study showed an increase in Alzheimer’s disease for all groups studied, but particularly among African Americans, among whom identification increased by 460 percent.

“The good news is these Medicare claims are telling us that African-Americans are receiving better access to care and are being properly diagnosed, especially African-American women who historically don’t see physicians regularly,” said Taylor, assistant professor of public policy at Duke. “The bad news is there will be an increase in treatment costs and more overall pressure on the Medicare system.”

According to the Alzheimer’s Association, as baby boomers enter the age of greatest risk the number of new cases will increase by nearly 1 million each year. The total number of people with the disease will explode from an estimated 4.5 million today to as many as 16 million by 2050. Current national direct and indirect costs of caring for individuals with Alzheimer’s have reached at least $100 billion, according to estimates used by the Association and the National Institute of Aging.

Another study presented at ICAD, by Henry A. Glick, Ph.D., School of Medicine, University of Pennsylvania, examined the costs of care during the 15-year period after a person has been diagnosed with Alzheimer’s disease. The data, from approximately 1,600 patients, analyzed the years of institutional care, hours of paid and informal care, and discounted costs of paid community, institutional and medical care. The results showed:

• The average cost per year to care for a man with Alzheimer’s was approximately $9,710.

• The average cost per year to care for a woman with Alzheimer’s was approximately $16,327 – almost twice as high as men. This is attributed to longer life expectancies, spending more time in institutions, and having more hours of paid and informal care.

• The cost of care in the later stages of the disease was substantially greater than the costs in earlier stages of the disease.

“We need more money invested for basic and clinical Alzheimer research,” said Glick. “Discovering methods to treat Alzheimer’s that are substantially more effective or less costly not only will improve the quality of life of those with Alzheimer’s, but will also lower health care costs.”

A study presented by Shalini L. Kulasingam, Ph.D., and colleagues at Duke University Medical Center, also found that costs rise dramatically as Alzheimer’s disease progresses. In a review of published studies tracking annual medical costs at different stages of disease severity, the researchers found that direct costs alone for individuals in the advanced stages were 60 to 200 percent higher than for those with mild Alzheimer’s.

The cost of care for those with Alzheimer’s isn’t only a concern in the United States. A study by Arthur Zbrozek, M.S., of Wyeth Research and colleagues showed that the total annual cost for formal dementia care across Europe is approximately $104 billion (87.22 billion Euros).

To expedite effective treatment and prevention of Alzheimer’s, the Alzheimer’s Association calls for:

• $1 billion in annual federal funding for Alzheimer research.

• Changing the way Americans think about Alzheimer’s. The Association is asking Americans to “Maintain Your Brain™” – learn more about what is known about Alzheimer’s; understand how managing lifestyle risk factors can improve brain health; and join the Association in advocating for a renewed commitment to research and improved care for those with Alzheimer’s.

• Establishing a targeted chronic care benefit within Medicare to control the high costs of care for beneficiaries with dementia and other complex chronic conditions.

• Enhancing care and support services for persons with Alzheimer’s by assuring that research findings are translated into improved care and treatments for patients.

A new Association report shows that medical research breakthroughs could result in nearly 3 million fewer Americans with the disease and $149 billion in annual Medicare and Medicaid savings by 2025. Find it at http://www.alz.org/

The 9th International Conference on Alzheimer’s Disease and Related Disorders (ICAD), presented by the Alzheimer’s Association, is the largest gathering of Alzheimer researchers in history. More than 4,500 scientists from around the world will present and discuss the findings of 2,000 studies showcasing the newest treatment advances in Alzheimer’s disease and steps toward prevention. ICAD will be held July 17-22, 2004, at the Pennsylvania Convention Center in Philadelphia, Pennsylvania.

The Alzheimer's Association is the world leader in Alzheimer research and support. Having awarded more than $165 million to more than 1,300 projects, the Alzheimer's Association is the largest private funder of Alzheimer research. For more information about Alzheimer's disease, visit www.alz.org  or call 800-272-3900.